sumatriptan has been researched along with substance p in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (76.47) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buzzi, MG; Moskowitz, MA | 1 |
Alessandri, M; Fanciullacci, M; Figini, M; Geppetti, P; Michelacci, S | 1 |
Connor, HE; O'Shaughnessy, CT; Waldron, GJ | 1 |
Butler, A; Connor, HE; O'Shaughnessy, CT; Worton, SP | 1 |
Bax, WA; Bos, E; Renzenbrink, GJ; Saxena, PR; Thijssen, EJ; Van Heuven-Nolsen, D | 1 |
Carter, D; Champney, M; Eglen, RM; Hwang, B | 1 |
Arvieu, L; Bourgoin, S; Cesselin, F; Feltz, P; Hamon, M; Mauborgne, A; Oliver, C | 1 |
Bax, WA; Bos, E; Ferrari, MD; Maassen VanDenBrink, A; Saxena, PR; Zijlstra, FJ | 1 |
Hargreaves, RJ; Hill, RG; Shepheard, SL; Williamson, DJ | 1 |
Bax, WA; De Vries, P; Heiligers, JP; Maassen VanDenBrink, A; Saxena, PR; Yocca, FD | 1 |
Buckingham, JC; Kennard, C; Rhodes, KF | 1 |
Sjaastad, O; White, LR | 1 |
Bischoff, A; Diener, H; Fetscher, C; Limmroth, V; Michel, MC; Wermelskirchen, D | 1 |
Bax, WA; Maassen VanDenBrink, A; Reekers, M; Saxena, PR | 1 |
Bhalla, P; de Vries, R; Saxena, PR; Sharma, HS; van den Broek, RW; VanDenBrink, AM | 1 |
Avezaat, CJ; Bogers, AJ; John, GW; MaassenVanDenBrink, A; Mulder, PG; Saxena, PR; van den Broek, RW | 1 |
Cunha-Vaz, JG; Gaspar, MN; Macedo, TR; Ribeiro, CA | 1 |
1 review(s) available for sumatriptan and substance p
Article | Year |
---|---|
The trigemino-vascular system and migraine.
Topics: Blood Proteins; Calcitonin Gene-Related Peptide; Cerebrovascular Disorders; Cranial Nerve Diseases; Dihydroergotamine; Dura Mater; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Substance P; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents | 1992 |
16 other study(ies) available for sumatriptan and substance p
Article | Year |
---|---|
Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.
Topics: Adult; Calcitonin Gene-Related Peptide; Cluster Headache; Humans; Male; Nitroglycerin; Remission Induction; Substance P; Sumatriptan | 1995 |
Lack of effect of sumatriptan and UK-14,304 on capsaicin-induced relaxation of guinea-pig isolated basilar artery.
Topics: Animals; Basilar Artery; Brimonidine Tartrate; Calcitonin Gene-Related Peptide; Capsaicin; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Indoles; Male; Quinoxalines; Ruthenium Red; Substance P; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Vasodilation | 1993 |
Sensory nerve-mediated relaxation of guinea-pig isolated pulmonary artery: prejunctional modulation by alpha 2-adrenoceptor agonists but not sumatriptan.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Calcitonin Gene-Related Peptide; Electric Stimulation; Guinea Pigs; Histamine; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Neuromuscular Junction; Neurons, Afferent; Piperazines; Pulmonary Artery; Pyrrolidines; Quinoxalines; Substance P; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Yohimbine | 1993 |
5-HT receptors mediating contractions of the isolated human coronary artery.
Topics: Adolescent; Adult; Arteries; Blood Platelets; Child; Child, Preschool; Coronary Vessels; Dose-Response Relationship, Drug; Ergotamine; Female; Humans; In Vitro Techniques; Infant; Ketanserin; Male; Metergoline; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Pindolol; Potassium; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Sumatriptan; Yohimbine | 1993 |
Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cloning, Molecular; Drug Interactions; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; N,N-Dimethyltryptamine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Substance P; Sumatriptan; Tryptamines | 1995 |
Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord.
Topics: Animals; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Male; Rats; Rats, Wistar; Spinal Cord; Substance P; Sumatriptan | 1996 |
Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Arteries; Child; Child, Preschool; Coronary Vessels; Female; Humans; In Vitro Techniques; Infant; Male; Middle Aged; Potassium; Prostaglandin Endoperoxides, Synthetic; Substance P; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents | 1996 |
Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies.
Topics: Afferent Pathways; Anesthetics; Animals; Calcitonin Gene-Related Peptide; Dura Mater; Electric Stimulation; Indoles; Isoindoles; Male; Microscopy, Video; Nerve Fibers; Peptide Fragments; Rats; Rats, Sprague-Dawley; Substance P; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.
Topics: Animals; Arteriovenous Anastomosis; Carotid Arteries; Coronary Vessels; Hemodynamics; Humans; In Vitro Techniques; Indoles; Jugular Veins; Migraine Disorders; Muscle Contraction; Muscle, Smooth, Vascular; Oxygen; Piperazines; Potassium; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Substance P; Sumatriptan; Swine; Vasoconstrictor Agents | 1998 |
The inhibition of nicotine-evoked relaxation of the guinea-pig isolated basilar artery by some analgesic drugs and progesterone.
Topics: Analgesics; Animals; Aspirin; Basilar Artery; Capsaicin; Dinoprost; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Migraine Disorders; NG-Nitroarginine Methyl Ester; Nicotine; Progesterone; Substance P; Sumatriptan; Vasodilation | 1999 |
Sumatriptan and sensory neuropeptide activity in subarachnoid haemorrhage: an hypothesis.
Topics: Animals; Calcitonin Gene-Related Peptide; Humans; Migraine Disorders; Subarachnoid Hemorrhage; Substance P; Sumatriptan; Vasoconstrictor Agents | 1995 |
Effects of alniditan on neurogenic oedema in the rat dura mater and on contraction of rat basilar artery.
Topics: Animals; Basilar Artery; Benzopyrans; Brain Edema; Capillary Permeability; Dose-Response Relationship, Drug; Dura Mater; Extravasation of Diagnostic and Therapeutic Materials; In Vitro Techniques; Ketanserin; Male; Oxadiazoles; Piperazines; Propylamines; Pyrimidines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Antagonists; Substance P; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B/1D receptor antagonist GR55562.
Topics: Benzamides; Coronary Vessels; Dinoprost; Dose-Response Relationship, Drug; Drug Interactions; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Potassium; Pyridines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Sumatriptan; Vasoconstrictor Agents | 2000 |
Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
Topics: Adult; Aged; Animals; Blood Vessels; Bradykinin; Cerebral Arteries; CHO Cells; Coronary Vessels; Cricetinae; Female; Humans; In Situ Hybridization; In Vitro Techniques; Male; Meningeal Arteries; Middle Aged; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; RNA, Messenger; Saphenous Vein; Serotonin Antagonists; Substance P; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.
Topics: Adult; Aged; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Meningeal Arteries; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Nitriles; Piperazines; Predictive Value of Tests; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Substance P; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2002 |
Effects of neuropeptides on the sumatriptan-disturbed circulation in the optic nerve head of rabbits.
Topics: Animals; Arterioles; Blood-Retinal Barrier; Calcitonin Gene-Related Peptide; Capsaicin; Dose-Response Relationship, Drug; Female; Male; Microinjections; Neurokinin A; Neurokinin B; Neurokinin-1 Receptor Antagonists; Neuropeptides; Optic Nerve; Peptide Fragments; Rabbits; Receptors, Calcitonin Gene-Related Peptide; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Retinal Vessels; Substance P; Sumatriptan; Vasodilation | 2004 |